Variation in fasting and non-fasting serum enterolactone concentrations in women of the Malmö Diet and Cancer cohort

European Journal of Clinical Nutrition

Volumn 62, Issue 8, 2008, Pages 1005-1009

  Sonestedt, E ^a   Ericson, U ^a   Gullberg, B ^a   Penalvo J L ^b   Adlercreutz, H ^b   Wirfalt E ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ENTEROLACTONE;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FLUOROIMMUNOASSAY; HUMAN; MIDDLE AGED; NUTRIENT CONCENTRATION; NUTRITIONAL ASSESSMENT; WOMEN'S HEALTH;

4-BUTYROLACTONE; BIOLOGICAL MARKERS; COHORT STUDIES; DIET; FASTING; FEMALE; FLUOROIMMUNOASSAY; HUMANS; LIGNANS; MIDDLE AGED; PHYTOESTROGENS; POSTPRANDIAL PERIOD; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 49349116831     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602811     Document Type: Article

References (30)

1. Adlercreutz H (2002). Phyto-oestrogens and cancer. Lancet Oncol 3, 364-373.
2. Adlercreutz H, Fotsis T, Lampe J, Wahala K, Makela T, Brunow G et al. (1993). Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry. Scand J Clin Lab Invest Suppl 215, 5-18.
3. Adlercreutz H, Fotsis T, Watanabe S, Lampe J, Wahala K, Makela T et al. (1994). Determinatibn of lignans and isoflavonoids in plasma by isotope dilution gas chromatography-mass spectrometry. Cancer Detect Prev 18, 259-271.
4. Adlercreutz H, Hockerstedt K, Bannwart C, Bloigu S, Hamalainen E, Fotsis T et al. (1987). Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 27, 1135-1144.
5. Adlercreutz H, Wang GJ, Lapcik O, Hampl R, Wahala K, Makela T et al. (1998). Time-resolved fluoroimmunoassay for plasma enterolactone. Anal Biochem 265, 208-215.
6. Berglund G, Elmstahl S, Janzon L, Larsson SA (1993). The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med 233, 45-51.
7. Bowey E, Adlercreutz H, Rowland I (2003). Metabolism of isoflavones and lignans by the gut microflora: A study in germ-free and human flora associated rats. Food Chem Toxicol 41, 631-636.
8. Clavel T, Henderson G, Alpert CA, Philippe C, Rigottier-Gois L, Dore J et al. (2005). Intestinal bacterial communities that produce active estrogen-like compounds enterodiol and enterolactone in humans. Appl Environ Microbiol 71, 6077-6085.
9. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE (1995). Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 4, 649-654.
10. Hausner H, Johnsen NF, Hallund J, Tetens I (2004). A single measurement is inadequate to estimate enterolactone levels in danish postmenopausal women due to large intraindividual variation. J Nutr 134, 1197-1200.
11. Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Wahala K, Deyama T et al. (2001). In vitro metabolism of plant lignans: New precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 49, 3178-3186.
12. Johnsen NF, Hausner H, Olsen A, Tetens I, Christensen J, Knudsen KE et al. (2004). Intake of whole grains and vegetables determines the plasma enterolactone concentration of Danish women. J Nutr 134 2691-2697.
13. Kilkkinen A, Pietinen P, Klaukka T, Virtamo J, Korhonen P, Adlercreutz H (2002). Use of oral antimicrobials decreases serum enterolactone concentration. Am J Epidemiol 155, 472-477.
14. Kilkkinen A, Stumpf K, Pietinen P, Valsta LM, Tapanainen H, Adlercreutz H (2001). Determinants of serum enterolactone concentration. Am J Clin Nutr 73, 1094-1100.
15. Lampe JW (2003). Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J Nutr 133 (Suppl 3), 956S-964S.
16. Li JH, Awad AB, Fink CS, Wu YW, Trevisan M, Muti P (2001). Measurement variability of plasma beta-sitosterol and campesterol, two new biomarkers for cancer prevention. Eur J Cancer Prev 10, 245-249.
17. Milder IE, Arts IC, van de Putte B, Venema DP, Hollman PC (2005). Lignan contents of Dutch plant foods: A database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr 93, 393-402.
18. Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE (2006). Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev 15, 972-978.
19. Penalvo JL, Haajanen KM, Botting N, Adlercreutz H (2005a). Quantification of lignans in food using isotope dilution gas chromatography/mass spectrometry. J Agric Food Chem 53, 9342-9347.
20. Penalvo JL, Heinonen SM, Aura AM, Adlercreutz H (2005b). Dietary sesamin is converted to enterolactone in humans. J Nutr 135, 1056-1062.
21. Rosner B, Spiegelman D, Willett WC (1992). Correction of logistic regression relative risk estimates and confidence intervals for random within-person measurement error. Am J Epidemiol 136, 1400-1413.
22. Stumpf K, Adlercreutz H (2003). Short-term variations in enterolactone in serum, 24-hour urine, and spot urine and relationship with enterolactone concentrations. Clin Chem 49, 178-181.
23. Stumpf K, Uehara M, Nurmi T, Adlercreutz H (2000). Changes in the time-resolved fluoroimmunoassay of plasma enterolactone. Anal Biochem 284, 153-157.
24. Stumpf K (2004). Serum Enterolactone as Biological Marker and in Breast Cancer: From Laboratory to Epidemiological Studies (dissertation University of Helsinki: Helsinki.
25. Tarpila S, Aro A, Salminen I, Tarpila A, Kleemola P, Akkila J et al. (2002). The effect of flaxseed supplementation in processed foods on serum fatty acids and enterolactone. Eur J Clin Nutr 56, 157-165.
26. Tworoger SS, Hankinson SE (2006). Use of biomarkers in epidemiologic studies: Minimizing the influence of measurement error in the study design and analysis. Cancer Causes Control 17, 889-899.
27. Vanharanta M, Voutilainen S, Lakka TA, van der Lee M, Adlercreutz H, Salonen JT (1999). Risk of acute coronary events according to serum concentrations of enterolactone: A prospective population-based case-control study. Lancet 354, 2112-2115.
28. Vanharanta M, Voutilainen S, Rissanen TH, Adlercreutz H, Salonen JT (2003). Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med 163, 1099-1104.
29. Vineis P (1997). Sources of variation in biomarkers. IARC Sci Publ 142, 59-71.
30. Zeleniuch-Jacquotte A, Adlercreutz H, Akhmedkharsov A, Toniolo P (1998). Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period. Cancer Epidemiol Biomarkers Prev 7, 885-889.